BKYI · Bio Key International Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $358.0K | $464.2K | $279.5K | - | $465.1K | $262.3K | $299.6K | - | $476.6K | $606.1K |
| Gross Profit | $1.19M | $1.23M | $1.33M | - | $1.68M | $879.0K | $1.88M | - | $1.34M | $1.32M |
| R&D | $683.6K | $636.0K | $595.8K | - | $652.2K | $591.2K | $607.5K | - | $558.7K | $558.2K |
| SG&A | $1.40M | $1.68M | $1.37M | - | $1.61M | $1.94M | $1.78M | - | $1.55M | $1.94M |
| Total Operating Expenses | $2.08M | $2.32M | $1.97M | - | $2.26M | $2.53M | $2.39M | - | $2.11M | $2.50M |
| D&A | - | - | $21.8K | - | - | - | $23.8K | - | - | - |
| Operating Income | ($892.2K) | ($1.08M) | ($640.6K) | - | ($580.4K) | ($1.65M) | ($508.9K) | - | ($765.6K) | ($1.18M) |
| Interest Expense | $13.2K | $25.6K | $1.4K | - | $98.6K | $56.8K | $1.4K | - | $45.7K | $56.8K |
| Income Tax | $0 | $0 | $0 | - | $0 | $0 | $0 | - | ($189) | $143.0K |
| Net Income | ($964.8K) | ($1.17M) | ($736.5K) | - | ($739.0K) | ($1.67M) | ($510.3K) | - | ($637.8K) | ($1.42M) |
| EPS - Basic | ($1.50) | ($2.00) | ($1.60) | - | ($3.90) | ($10.00) | ($3.20) | - | ($12.60) | ($28.80) |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.04M | $2.28M | $3.13M | $437.6K | $1.80M | $1.26M | $690.4K | $511.4K | $307.1K | $565.5K |
| Accounts Receivable | $959.5K | $983.5K | $803.3K | $718.2K | $1.93M | $904.0K | $701.8K | $1.20M | $2.80M | $3.18M |
| Inventory | $394.2K | $318.5K | $357.8K | $378.3K | $386.9K | $433.2K | $440.2K | $445.7K | $4.29M | $4.38M |
| Accounts Payable | $655.6K | $889.0K | $568.8K | $818.2K | $1.56M | $1.54M | $1.21M | $1.32M | $1.66M | $1.86M |
| Current Assets | $3.75M | $4.04M | $4.59M | $1.89M | $4.55M | $3.01M | $2.27M | $2.62M | $7.82M | $8.53M |
| Total Assets | $10.11M | $10.52M | $11.18M | $8.62M | $6.40M | $4.80M | $4.17M | $4.52M | $9.75M | $10.58M |
| Current Liabilities | $2.96M | $3.53M | $3.47M | $4.55M | $5.87M | $5.57M | $3.32M | $3.21M | $6.03M | $6.28M |
| Long-term Debt | - | $0 | $11.7K | $44.8K | $83.9K | $114.7K | $149.9K | $188.8K | $221.6K | $255.2K |
| Total Liabilities | $4.07M | $3.66M | $3.66M | $4.84M | $6.27M | $5.86M | $3.63M | $3.45M | $6.43M | $6.74M |
| Stockholders' Equity | $6.05M | $6.85M | $7.53M | $3.77M | $133.0K | ($1.06M) | $535.7K | $1.06M | $3.31M | $3.85M |
| Retained Earnings | ($132.18M) | ($131.21M) | ($130.04M) | ($129.31M) | ($127.92M) | ($127.18M) | ($125.52M) | ($125.01M) | ($118.83M) | ($118.20M) |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($835.3K) | - | - | - | $297.1K | - | - | - |
| Investing Cash Flow | - | - | ($4.6K) | - | - | - | ($1.9K) | - | - | - |
| Financing Cash Flow | - | - | $3.53M | - | - | - | ($53.9K) | - | - | - |
| CapEx | - | - | $1.9K | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | ($837.2K) | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | 1.14 | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -9.5% | -11.1% | -6.6% | - | -11.5% | -34.7% | -12.2% | - | -6.5% | -13.4% |
| Return on equity | -16.0% | -17.0% | -9.8% | - | -555.4% | 157.8% | -95.3% | - | -19.2% | -37.0% |
| Return on invested capital | - | -12.5% | -6.7% | - | -211.4% | - | -58.6% | - | -17.1% | -22.7% |
| Liquidity | ||||||||||
| Current ratio | 1.26 | 1.14 | 1.32 | 0.41 | 0.78 | 0.54 | 0.68 | 0.82 | 1.30 | 1.36 |
| Quick ratio | 1.13 | 1.05 | 1.22 | 0.33 | 0.71 | 0.46 | 0.55 | 0.68 | 0.59 | 0.66 |
| Cash ratio | 0.69 | 0.64 | 0.90 | 0.10 | 0.31 | 0.23 | 0.21 | 0.16 | 0.05 | 0.09 |
| Leverage | ||||||||||
| Debt / Equity | - | 0.00 | 0.00 | 0.01 | 0.63 | -0.11 | 0.28 | 0.18 | 0.07 | 0.07 |
| Debt / Assets | - | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.04 | 0.04 | 0.02 | 0.02 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -67.7x | -42.3x | -472.4x | - | -5.9x | -29.1x | -375.3x | - | -16.8x | -20.7x |
| Equity multiplier | 1.67 | 1.53 | 1.49 | 2.28 | 48.10 | -4.54 | 7.78 | 4.25 | 2.94 | 2.75 |
| Liabilities / Assets | 0.40 | 0.35 | 0.33 | 0.56 | 0.98 | 1.22 | 0.87 | 0.76 | 0.66 | 0.64 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 0.91 | 1.46 | 0.78 | - | 1.20 | 0.61 | 0.68 | - | 0.11 | 0.14 |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 402d | 250d | 467d | - | 304d | 603d | 536d | - | 3285d | 2640d |
| Days payable outstanding | 668d | 699d | 743d | - | 1228d | 2143d | 1476d | - | 1268d | 1118d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -29.1% | 40.2% | -29.4% | - | 25.3% | -33.5% | -16.9% | - | 36.8% | 8.1% |
| Operating income growth (YoY) | -53.7% | 34.5% | -25.9% | - | 24.2% | -40.4% | -42.0% | - | 67.6% | 24.8% |
| Net income growth (YoY) | -30.6% | 30.0% | -44.3% | - | -15.9% | -17.2% | -77.0% | - | 73.5% | 17.2% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 4443.7% | - | 1305.0% | 254.7% | -96.0% | - | -89.6% | -79.9% | -70.4% | -71.8% |
Peer comparison
Same SIC group: Services-Prepackaged Software
Comparing BIO KEY INTERNATIONAL INC against the 5 most active filers in the same SIC group.